Pubdiz
Taipei Medical University

Pubdiz from Gene to Disease ��] ��Ʈw

A B C D E F G H I J K L M N O P Q R X Y Z



Gene Symbol
Gene NameAliasesPrevious_Symbol

HBA1

hemoglobin, alpha 1


Gene HBA1 gene interaction
View Neighborhood Gene

Result number fewer <<<< << < ALL > >> >>> more

MeSH term
FrequencyCondition_Probility

Adolescent

3652.0

Adult

7011.0

Blood Glucose/*metabolism

10540.0

Child

2131.0

Diabetes Mellitus, Type 1/blood/*physiopathology

2668.0

English Abstract

1681.0

Exercise/*physiology

20.0

Female

8851.0

Hemoglobin A, Glycosylated/analysis

32374.0

Humans

12080.0

Hydrocortisone/blood

71.0

Male

8221.0

Aged

2920.0

Comparative Study

3151.0

Diabetes Mellitus, Type 2/*blood/diagnosis

266.0

Logistic Models

81.0

Middle Aged

5541.0

Predictive Value of Tests

120.0

Probability

30.0

Prognosis

240.0

Prospective Studies

872.0

Research Support, Non-U.S. Gov't

4510.0

Sensitivity and Specificity

90.0

Severity of Illness Index

70.0

alpha-Macroglobulins/*analysis

313.0

African Continental Ancestry Group

51.0

Blood Glucose/analysis

21333.0

Blood Pressure/physiology

74.0

*Diabetes Complications

1120.0

Retrospective Studies

240.0

Risk Factors

861.0

South Africa/epidemiology

23.0

Time Factors

1231.0

Diabetes Mellitus, Type 2/*drug therapy

1770.0

Double-Blind Method

482.0

Gliclazide/*therapeutic use

6100.0

Glyburide/*therapeutic use

990.0

Hypoglycemic Agents/*therapeutic use

2136.0

Oxidative Stress/*drug effects

25.0

Blood Pressure/drug effects

91.0

Hypertension/complications/drug therapy

321.0

Kidney/physiopathology

35.0

Proteinuria

37.0

Diabetes Mellitus, Type 2/*complications

821.0

Blood Pressure

477.0

Case-Control Studies

160.0

Cohort Studies

261.0

Diabetes Mellitus, Type 1/*complications/physiopathology

562.0

Glomerular Filtration Rate

97.0

Kidney/*pathology

47.0

Patient Selection

21.0

Reference Values

1102.0

Age of Onset

131.0

European Continental Ancestry Group

60.0

Incidence

181.0

Pennsylvania/epidemiology

214.0

Research Support, U.S. Gov't, P.H.S.

1130.0

Anxiety

428.0

*Awareness

222.0

Blood Glucose/analysis/*physiology

2100.0

Blood Glucose Self-Monitoring

17100.0

Follow-Up Studies

1042.0

*Patient Education

2259.0

Psychological Tests

37.0

Anthropometry

83.0

Energy Metabolism

21.0

Long-Term Care

35.0

Statistics, Nonparametric

90.0

Thailand

21.0

Treatment Outcome

100.0

Aged, 80 and over

410.0

Diabetes Complications

2416.0

*Population Surveillance

25.0

Prevalence

292.0

*Quality of Life

55.0

Questionnaires

366.0

England/epidemiology

35.0

Blood Glucose/*analysis

7459.0

Cross-Over Studies

60.0

Diabetes Mellitus, Type 1/blood/*drug therapy/psychology

4100.0

Diabetic Diet

2268.0

Energy Intake

73.0

Insulin/*administration & dosage/therapeutic use

1275.0

Medical Records

22.0

Quality of Life

42.0

Self Care

1058.0

Stress, Psychological

27.0

India/epidemiology

44.0

Sex Distribution

20.0

Diabetes Mellitus/*blood/physiopathology

225.0

Fibrinogen/*metabolism

34.0

Hyperglycemia/*blood

640.0

Biological Markers/blood

231.0

Disease Progression

140.0

Fasting

4113.0

Fructosamine/blood

562.0

Hemoglobin A, Glycosylated/*analysis

20191.0

Serum Albumin/analysis

52.0

Chromatography, Ion Exchange

154.0

Animals

200.0

Base Composition

20.0

Child, Preschool

810.0

Mice

30.0

Phenotype

70.0

Syndrome

20.0

Drug Administration Schedule

313.0

Drug Therapy, Combination

342.0

Insulin/*therapeutic use

5162.0

Sulfonylurea Compounds/therapeutic use

650.0

Treatment Failure

41.0

Age Factors

481.0

Body Mass Index

373.0

Parity

32.0

Pregnancy

631.0

Chromatography, High Pressure Liquid

181.0

Hemoglobins, Abnormal/*analysis

420.0

Isoelectric Focusing

40.0

Diabetes Mellitus, Type 2/*blood/physiopathology

425.0

Diabetic Angiopathies/*blood

1047.0

Diabetic Nephropathies/blood

541.0

Diabetic Retinopathy/blood

947.0

Erythrocytes/enzymology

30.0

Glutathione Peroxidase/*blood

211.0

Lipid Peroxides/blood

312.0

Lipoproteins, HDL Cholesterol/blood

344.0

Lipoproteins, LDL Cholesterol/blood

193.0

Superoxide Dismutase/*blood

27.0

Thiobarbituric Acid Reactive Substances/analysis

29.0

Triglycerides/blood

946.0

Confidence Intervals

30.0

Demography

76.0

Diabetic Neuropathies/epidemiology

2100.0

Diabetic Retinopathy/epidemiology

990.0

Morbidity

46.0

Poverty

29.0

Proteinuria/epidemiology

266.0

*Socioeconomic Factors

360.0

Leg/*blood supply

26.0

Smoking/adverse effects

31.0

*Glucose Tolerance Test

1933.0

Insulin Resistance

95.0

Lipids/blood

274.0

Hemoglobin E/*genetics

240.0

Infant, Newborn

340.0

Pedigree

20.0

Fibrinogen/analysis

63.0

Blood Glucose/metabolism

15922.0

Glucose Clamp Technique

1312.0

Insulin/administration & dosage/therapeutic use

1076.0

*Insulin Resistance

115.0

Biological Markers/*blood

74.0

Diabetes Mellitus, Type 1/blood/physiopathology

266.0

Diabetes Mellitus, Type 2/blood/physiopathology

240.0

Fluorescein Angiography

54.0

Base Sequence

20.0

Molecular Sequence Data

20.0

Cholesterol/blood

877.0

Placebos

52.0

Postprandial Period

55.0

Cross-Sectional Studies

272.0

Diabetes Mellitus, Type 2/*drug therapy/*physiopathology/psychology

2100.0

Motivation

210.0

Norway

65.0

Primary Health Care

214.0

Antigens, CD/analysis

20.0

Platelet Aggregation/drug effects

41.0

Analysis of Variance

401.0

C-Peptide/*urine

375.0

Creatinine/blood

134.0

Islets of Langerhans/*physiopathology

956.0

Diabetes Mellitus/*diagnosis

9100.0

Fetal Hemoglobin/*metabolism

233.0

Hemoglobin A/*metabolism

746.0

Hemoglobin A, Glycosylated

266.0

Insulin/metabolism

21.0

*Body Mass Index

22.0

C-Peptide/*blood

1336.0

Diabetes Mellitus, Type 2/blood/*complications

840.0

Diabetic Angiopathies/epidemiology

675.0

Diabetic Nephropathies/epidemiology

2100.0

Germany/epidemiology

21.0

Randomized Controlled Trials

51.0

Albuminuria/*epidemiology

571.0

Diabetes Mellitus, Type 1/*physiopathology/urine

375.0

Diabetic Nephropathies/*epidemiology

250.0

Multivariate Analysis

171.0

Smoking

174.0

Diabetes Mellitus, Type 1/*complications

1348.0

Forecasting

20.0

Hyperglycemia/complications

333.0

Hypertension/complications

711.0

Diabetes Mellitus/blood

3145.0

Blood Glucose/drug effects/metabolism

625.0

Glyburide/therapeutic use

777.0

Hemoglobin A, Glycosylated/metabolism

9866.0

Hypoglycemic Agents/therapeutic use

1534.0

Diabetes Mellitus, Type 2/metabolism/*physiopathology

250.0

Longitudinal Studies

333.0

Obesity/*physiopathology

23.0

Radioimmunoassay

150.0

Calcium/*urine

26.0

Diabetes Mellitus, Type 1/*metabolism

2442.0

Sex Characteristics

183.0

Diabetes Mellitus, Type 2/*drug therapy/metabolism

228.0

Regression Analysis

573.0

Sex Factors

342.0

Capillaries

35.0

Diabetes Mellitus/*blood

5356.0

Chylomicrons/*blood

26.0

Diabetes Mellitus, Type 2/*blood

4034.0

Oxidation-Reduction

70.0

Research Support, U.S. Gov't, Non-P.H.S.

110.0

Glucose/*metabolism

42.0

Biological Markers

40.0

Coronary Disease/*blood

23.0

Diabetes Mellitus, Type 1/*blood

9063.0

Insulin Resistance/physiology

36.0

Particle Size

20.0

Diabetes Mellitus, Type 1/*physiopathology

2547.0

Insulin-Like Growth Factor I/*metabolism

53.0

Albuminuria/*etiology

250.0

Diabetic Angiopathies/etiology

466.0

Histocompatibility Testing

30.0

*Dietary Supplements

23.0

Electrophysiology

40.0

Motor Neurons/physiology

714.0

Neural Conduction/*drug effects

233.0

Blood Glucose Self-Monitoring/statistics & numerical data

2100.0

Diabetes Mellitus, Type 1/blood/*complications

675.0

Hypoglycemia/*etiology

228.0

Insulin/blood

284.0

Pregnancy Trimester, First

82.0

Pregnancy Trimester, Second

52.0

Deoxyglucose/blood

2100.0

Adaptation, Psychological

612.0

Diabetes Mellitus, Type 1/blood/*psychology/rehabilitation

2100.0

Germany

61.0

*Internal-External Control

428.0

*Sick Role

321.0

Acute Disease

30.0

Chi-Square Distribution

70.0

Indians, North American

515.0

Odds Ratio

70.0

C-Peptide/blood

5532.0

Diabetes Mellitus, Type 1/*drug therapy

2379.0

Enzyme Inhibitors/adverse effects/*therapeutic use

225.0

Hypoglycemic Agents/adverse effects/*therapeutic use

583.0

Acarbose

981.0

Trisaccharides/adverse effects/*therapeutic use

2100.0

India

51.0

Proteinuria/*complications

250.0

*Fear

233.0

Hypoglycemia/etiology/*psychology

3100.0

*Mother-Child Relations

228.0

Chronic Disease

100.0

Boronic Acids

480.0

*African Continental Ancestry Group

65.0

*European Continental Ancestry Group

55.0

Systole

67.0

Body Weight/drug effects

84.0

Dose-Response Relationship, Drug

160.0

Glucose Tolerance Test

6215.0

Diabetes Mellitus, Type 1/*blood/genetics

266.0

Acetylglucosaminidase/*blood

360.0

Biological Markers/blood/urine

36.0

Blood Proteins/analysis

31.0

Deoxyglucose/*blood

266.0

*Birth Weight

923.0

Pregnancy Outcome

31.0

Pregnancy in Diabetics/blood/*physiopathology

3100.0

Hypertension/epidemiology

37.0

Korea/epidemiology

23.0

Romania

211.0

Diabetes Mellitus, Type 2/drug therapy/*metabolism

240.0

Enalapril/*pharmacology

26.0

Hypoglycemic Agents/administration & dosage/*therapeutic use

444.0

Insulin/administration & dosage/*therapeutic use

1381.0

Lipoproteins/blood

92.0

Single-Blind Method

41.0

Hyperglycemia/prevention & control

375.0

Hypoglycemic Agents/administration & dosage/therapeutic use

250.0

Postpartum Period/blood

210.0

Diabetes Mellitus, Type 2/*physiopathology

825.0

Heart Rate/drug effects

72.0

Hematocrit

41.0

Hemoglobin A, Glycosylated/drug effects

266.0

Diabetes Mellitus/blood/*diagnosis

8100.0

Protein Precursors/*analysis

312.0

Albuminuria

1020.0

Diabetic Retinopathy/*epidemiology/*physiopathology

2100.0

Survival Analysis

20.0

Creatinine/metabolism

79.0

Diabetes Mellitus, Type 2/blood/*physiopathology

631.0

Diabetic Angiopathies/blood/*physiopathology

240.0

Diabetic Nephropathies/blood/*physiopathology

2100.0

Alkaline Phosphatase/blood

32.0

*Bone Density

32.0

Calcium/blood

41.0

Phosphorus/blood

38.0

Spain/epidemiology

21.0

Diabetes Mellitus, Type 2/blood/*drug therapy

3269.0

Sulfonylurea Compounds/*therapeutic use

1161.0

Biological Markers/analysis

30.0

Fructosamine/*blood

2100.0

Mass Screening/methods

24.0

Infant

290.0

Valsalva Maneuver

337.0

Diabetes Mellitus, Type 1/*metabolism/physiopathology

375.0

Chromatography, Gel

20.0

Hyperglycemia/blood

222.0

Molecular Weight

40.0

Linear Models

20.0

Lipid Peroxidation/*physiology

211.0

Lipoproteins, LDL/*blood

31.0

Hypoglycemic Agents/administration & dosage

240.0

Insulin/administration & dosage

1562.0

Diabetic Retinopathy/*physiopathology

646.0

Israel

42.0

Jews

22.0

Puberty

811.0

Socioeconomic Factors

169.0

Diabetes Mellitus, Type 1/*therapy

555.0

*Diet

31.0

Exercise

76.0

Islets of Langerhans/*metabolism

23.0

Insulin/therapeutic use

6961.0

Social Adjustment

220.0

Angiotensin-Converting Enzyme Inhibitors/*therapeutic use

41.0

Diabetic Nephropathies/*prevention & control

240.0

Enalapril/*therapeutic use

36.0

Lipids/blood/*metabolism

211.0

Diabetes Mellitus, Type 2/blood/complications

375.0

Diabetic Angiopathies/*etiology

571.0

Diabetic Retinopathy/etiology

240.0

Risk

161.0

Albuminuria/*urine

433.0

Blood Pressure/*physiology

22.0

Blood Pressure Monitoring, Ambulatory

24.0

Diabetes Mellitus, Type 1/blood/*physiopathology/urine

240.0

Glomerular Filtration Rate/*physiology

233.0

Autoantibodies/*analysis

41.0

Enzyme-Linked Immunosorbent Assay

20.0

Glycosylation

151.0

Circadian Rhythm/*physiology

22.0

Insulin/*administration & dosage/*therapeutic use

3100.0

Swine

80.0

Aldehyde Reductase/*antagonists & inhibitors

213.0

Diabetic Neuropathies/blood

250.0

Health Knowledge, Attitudes, Practice

412.0

Interpersonal Relations

521.0

*Adaptation, Psychological

310.0

Diabetic Nephropathies/*blood

630.0

Erythrocytes/*metabolism

115.0

Hydrogen-Ion Concentration

70.0

Sodium/blood

32.0

Uremia/blood

316.0

Autoantibodies/blood

52.0

Islets of Langerhans/immunology

821.0

Membrane Glycoproteins/blood

26.0

*Platelet Activation

32.0

Risk Assessment

20.0

Thrombospondins

21.0

Combined Modality Therapy

100.0

Personality Inventory

25.0

Diabetes Mellitus, Type 1/*blood/drug therapy

2468.0

Growth Hormone/*blood

52.0

Recombinant Proteins/therapeutic use

30.0

Factor Analysis, Statistical

25.0

Diabetes Mellitus, Type 1/*blood/physiopathology

842.0

*Obesity

1019.0

Blood Pressure/drug effects/physiology

25.0

Diabetic Neuropathies/*drug therapy/physiopathology

266.0

Diabetes Mellitus, Type 1/*blood/metabolism

450.0

Hemoglobin A, Glycosylated/*metabolism

4489.0

Dental Plaque Index

417.0

Periodontal Diseases/*etiology/pathology

266.0

Periodontal Index

612.0

Family Characteristics

318.0

Hemoglobins/analysis

41.0

Hospitalization

54.0

Hypoglycemia/epidemiology

2100.0

*Blood Pressure

108.0

Diastole

57.0

*Blood Glucose Self-Monitoring

1090.0

Family Practice

26.0

*Inpatients

2100.0

Autonomic Nervous System Diseases/*etiology

266.0

Diabetes Mellitus, Type 2/*complications/metabolism

250.0

Heart Rate/physiology

22.0

DMF Index

218.0

Lactobacillus/isolation & purification

375.0

Streptococcus mutans/isolation & purification

2100.0

Diabetes Mellitus, Type 1/*complications/drug therapy/metabolism

2100.0

Albuminuria/etiology

545.0

Kidney/*physiopathology

58.0

Renal Circulation

38.0

Prolactin/*blood

20.0

Autonomic Nervous System/*physiopathology

420.0

Autonomic Nervous System Diseases/*epidemiology

2100.0

Diabetic Neuropathies/*epidemiology

4100.0

Proportional Hazards Models

20.0

Alveolar Bone Loss/complications

2100.0

Diabetes Mellitus, Type 2/*blood/complications/drug therapy

266.0

Hypoglycemia/prevention & control

2100.0

Arizona/epidemiology

325.0

World Health Organization

22.0

Diabetes Mellitus, Type 2/*therapy

2100.0

Evaluation Studies

192.0

*Therapy, Computer-Assisted

457.0

Colony Count, Microbial

22.0

Glucose/analysis

213.0

Hyperglycemia/physiopathology

240.0

Secretory Rate

26.0

Cost-Benefit Analysis

21.0

Reproducibility of Results

70.0

*Self Care

861.0

Lipoprotein(a)/*blood

22.0

Diabetic Retinopathy

375.0

Reflex

211.0

Diabetic Neuropathies/*blood/physiopathology

266.0

Erythrocyte Membrane/*enzymology

26.0

Na(+)-K(+)-Exchanging ATPase/*blood

210.0

Neural Conduction

1919.0

Peroneal Nerve/physiopathology

228.0

Sural Nerve/physiopathology

330.0

*Diabetic Diet

1359.0

Glucosamine/*analogs & derivatives/therapeutic use

4100.0

Metabolic Clearance Rate

72.0

alpha-Glucosidases/*antagonists & inhibitors

750.0

Body Height

63.0

Carrier Proteins/*blood

52.0

Diabetes Mellitus, Type 1/blood/*metabolism

770.0

Growth

36.0

Autoantibodies/*immunology

20.0

Diabetes Mellitus, Type 1/complications/*immunology

250.0

Immunoglobulin A/*blood

27.0

Immunosuppressive Agents/therapeutic use

20.0

Preoperative Care

21.0

Autoantibodies/*blood

31.0

Glutamate Decarboxylase/immunology

26.0

Islets of Langerhans/immunology/*secretion

350.0

Alcohol Drinking

53.0

Apolipoproteins/blood

73.0

Peptide Fragments/*blood

22.0

Circadian Rhythm

124.0

Diabetes Mellitus, Type 2/*metabolism

714.0

Fatty Acids, Nonesterified/blood

136.0

Infusions, Intravenous

40.0

Random Allocation

357.0

Diabetic Nephropathies/physiopathology

426.0

Diabetic Neuropathies/physiopathology

457.0

Diabetic Retinopathy/physiopathology

861.0

Electroencephalography

20.0

*Evoked Potentials, Auditory

26.0

Diabetes Mellitus, Type 1/*blood/*psychology

3100.0

Interviews

37.0

Diabetes Mellitus, Type 1/blood/*complications/physiopathology

4100.0

Puberty/*blood

317.0

Thyroxine/blood

93.0

Electrophoresis, Agar Gel/*methods

212.0

Fetal Hemoglobin/*analysis

531.0

Pregnancy in Diabetics/*blood

2058.0

Autonomic Nervous System/physiopathology

414.0

Diabetic Neuropathies/blood/*physiopathology

555.0

Diabetic Angiopathies/*epidemiology

250.0

Abnormalities/*epidemiology

250.0

Maternal Age

22.0

*Pregnancy in Diabetics

225.0

Diabetic Neuropathies/*drug therapy

360.0

Diabetic Nephropathies/*blood/therapy

2100.0

Kidney Failure, Chronic/*blood/therapy

35.0

*Peritoneal Dialysis

23.0

Blood Glucose

910.0

Glycosuria

1058.0

Diabetes Mellitus, Type 1/*blood/*therapy

2100.0

Hospitals, University

411.0

Patient Care Team

211.0

Skinfold Thickness

68.0

Urban Population

21.0

Diabetes Mellitus, Type 2/*blood/complications

315.0

Diabetic Angiopathies/blood

428.0

Diabetic Retinopathy/*blood

1280.0

Hypertension/etiology

36.0

*Albuminuria

1858.0

Heart Rate

93.0

Albuminuria/urine

525.0

Biopsy

20.0

Microscopy, Electron

30.0

Hydroxyproline/urine

211.0

Diabetes Mellitus, Type 2/*blood/therapy

375.0

*Circadian Rhythm

52.0

Growth Hormone/blood

135.0

Drug Stability

31.0

France

20.0

Quality Control

52.0

Diabetes Mellitus, Type 1/blood/*drug therapy

3790.0

Insulin/administration & dosage/*adverse effects

3100.0

Patient Compliance

2315.0

Patient Education

1016.0

*Ethnic Groups

21.0

Gestational Age

80.0

Pregnancy/*blood

74.0

Prenatal Care

28.0

Great Britain

52.0

Diabetes Mellitus, Type 2/blood/*metabolism

444.0

Insulin/administration & dosage/blood/*pharmacology

228.0

Kinetics

160.0

Liver/drug effects/*metabolism

22.0

Lipid Peroxides/*blood

317.0

Malondialdehyde/blood

34.0

Drug Tolerance

21.0

Food

75.0

*Primary Health Care

330.0

Glycerol/blood

410.0

Lipoproteins, VLDL/blood

41.0

Liver/*metabolism

20.0

Intelligence

412.0

Psychomotor Performance

26.0

Diagnosis, Differential

60.0

*Erythrocyte Aging

29.0

*Erythrocyte Deformability

337.0

Cesarean Section

34.0

Diabetes Mellitus, Type 1/blood/*physiopathology/rehabilitation

2100.0

*Growth

310.0

Japan

30.0

Weight Gain

34.0

*Health Knowledge, Attitudes, Practice

414.0

Diabetes Mellitus, Type 1/drug therapy/*psychology

2100.0

Emotions

313.0

Hypoglycemia

240.0

*Social Adjustment

2100.0

Social Support

24.0

*Stress, Psychological

213.0

*Patient Compliance

1022.0

Diabetes Mellitus/blood/*drug therapy

571.0

Diabetes Mellitus, Type 1/complications/*physiopathology

562.0

Glomerular Filtration Rate/physiology

210.0

Acromegaly/blood/*drug therapy

214.0

Insulin-Like Growth Factor I/analysis

21.0

Albuminuria/blood

228.0

Diabetes Mellitus, Type 1/physiopathology

327.0

Diabetes Mellitus, Type 2/physiopathology

216.0

Hypertension/*drug therapy

31.0

Neural Conduction/drug effects

323.0

Temperature

101.0

Vibration

535.0

Diabetes Mellitus, Type 2/blood/physiopathology/*urine

5100.0

Eating

1410.0

Adenosine Diphosphate/pharmacology

32.0

Administration, Oral

141.0

Cholesterol Esters/blood

32.0

Diabetes Mellitus, Type 2/*blood/*drug therapy

218.0

Fatty Acids/*blood

517.0

Linoleic Acid

27.0

Linoleic Acids/blood

222.0

Oleic Acid

23.0

Oleic Acids/blood

240.0

Phospholipids/blood

75.0

Diabetes Mellitus, Type 2/blood/*physiopathology/urine

250.0

Polymorphism, Genetic/*genetics

20.0

Arizona

26.0

Birth Weight

138.0

Reference Standards

31.0

Pirenzepine/pharmacology

225.0

Pyridostigmine Bromide/pharmacology

214.0

Gabon

220.0

Internal Medicine

250.0

Apolipoproteins A/*blood

24.0

Apolipoproteins B/blood

20.0

Cholesterol/*blood

135.0

Diabetes Mellitus, Type 1/blood

1959.0

Lipoproteins, HDL Cholesterol/*blood

41.0

Pregnancy Trimester, Third

84.0

Proteinuria/blood

225.0

Triglycerides/*blood

102.0

Glucagon/blood

1010.0

Insulin/*secretion

45.0

Epinephrine/blood

43.0

Hormones/*blood

21.0

Hypoglycemia/*blood

430.0

Norepinephrine/blood

42.0

Diabetes Mellitus, Type 1/*blood/complications

538.0

Growth Hormone/*secretion

21.0

Family/psychology

233.0

Patient Admission

216.0

Blood Bactericidal Activity

22.0

Hemoglobin A/metabolism

660.0

Phagocytosis

30.0

Diabetes Mellitus/*blood/drug therapy

1664.0

Insulin Infusion Systems

1973.0

African Americans

21.0

Hypoglycemic Agents/*administration & dosage

327.0

Insulin/*administration & dosage

2573.0

Trisaccharides/*administration & dosage

2100.0

Diabetes Mellitus, Type 1/*enzymology

436.0

Diabetes Mellitus, Type 2/*enzymology

337.0

Electrochemistry

22.0

Diabetes Mellitus, Type 2/*urine

240.0

Autoantibodies/analysis

42.0

Flow Cytometry

30.0

Diabetic Retinopathy/complications

350.0

Hemoglobin A/analysis

2672.0

Patient Acceptance of Health Care

521.0

Periodontal Pocket/pathology

233.0

Dietary Fats/administration & dosage

33.0

Infusions, Parenteral

21.0

Ambulatory Care

412.0

Diabetes Mellitus/*blood/therapy

880.0

Electrophoresis

20.0

Immunoradiometric Assay

32.0

Diabetic Retinopathy/diagnosis

250.0

Clinical Trials

424.0

Sulfonylurea Compounds/adverse effects/*therapeutic use

3100.0

Capillaries/pathology

24.0

Glucagon/diagnostic use

650.0

Niacinamide/*therapeutic use

3100.0

Insulin/*administration & dosage/blood/therapeutic use

2100.0

Insulin, Isophane/administration & dosage/therapeutic use

2100.0

Patient Satisfaction

37.0

Bone Density/*physiology

23.0

Creatinine/urine

87.0

Endothelins/*blood

311.0

Glipizide/*therapeutic use

4100.0

Lactates/blood

45.0

Lactic Acid

34.0

Metformin/*therapeutic use

626.0

Hyperglycemia/blood/*physiopathology

250.0

Posture

22.0

Respiration

47.0

2,3-Diphosphoglycerate

214.0

Body Weight

304.0

Insulin/*pharmacology

41.0

Oxygen/metabolism

20.0

Rats

30.0

Diabetic Neuropathies/*physiopathology

1071.0

Diabetes Mellitus, Type 1/*immunology

68.0

Fructosamine

5087.0

Hexosamines/blood

1982.0

Statistics

51.0

Chromatography, Affinity

91.0

Urea/blood

39.0

Uremia/*blood

618.0

Diabetes Mellitus, Type 1/*blood/urine

337.0

*Glycoproteins

91.0

Lipoproteins/*blood

172.0

Occupations

214.0

Diabetes Mellitus, Type 1/blood/physiopathology/*urine

480.0

Diabetes Mellitus, Type 1/blood/*therapy

685.0

Microcomputers

330.0

Diabetes Mellitus, Type 1/metabolism/*therapy

2100.0

Glycosuria/urine

480.0

Apolipoproteins B/analysis

27.0

Hemostasis

32.0

Lipids/*blood

203.0

Ultracentrifugation

21.0

Alpha-Globulins/*urine

266.0

Diabetic Nephropathies/prevention & control

250.0

Kidney Function Tests

43.0

Renin/blood

20.0

Insulin/blood/*secretion

24.0

Mass Screening

21.0

Diabetes Mellitus, Type 2/blood/*diet therapy

571.0

Dietary Carbohydrates

313.0

Dietary Fats

25.0

Dietary Fiber

240.0

Lipoprotein Lipase/blood

33.0

Lipoproteins, HDL/blood

145.0

Diabetes Mellitus/physiopathology

214.0

Diabetic Retinopathy/complications/physiopathology

2100.0

Antibodies, Monoclonal

40.0

Diabetes Mellitus, Type 1/blood/*diet therapy/drug therapy

2100.0

*Eating

23.0

*Weight Gain

211.0

Exercise Test

20.0

Hemodynamic Processes

42.0

C-Peptide/analysis

654.0

*Insulin Infusion Systems

3778.0

Lipids/metabolism

20.0

Lipoproteins, LDL/blood

52.0

Platelet Aggregation/*physiology

28.0

*Kidney Transplantation

40.0

*Pancreas Transplantation

316.0

Diabetic Nephropathies/*physiopathology

436.0

*Colorimetry

228.0

*Mass Screening

35.0

Thiobarbiturates/diagnostic use

266.0

Diabetes Mellitus, Type 1/*blood/*physiopathology

266.0

Sensory Thresholds

425.0

*Electrocardiography

35.0

Reflex, Pupillary

266.0

*Glomerular Filtration Rate

312.0

Regional Blood Flow

21.0

Diabetes Mellitus, Type 2/blood

1338.0

Superoxides/*blood

211.0

Arteriosclerosis/blood

28.0

Carbohydrates/metabolism

23.0

Diabetes Mellitus/metabolism

38.0

Insulin/*blood

63.0

Hemoglobins/*analysis

47.0

Pediatrics

225.0

United States

30.0

Diabetic Angiopathies/blood/*epidemiology

2100.0

Pennsylvania

28.0

Skin/*metabolism

21.0

Pregnancy in Diabetics/blood

654.0

Health Status

33.0

*Social Support

327.0

Leukocytes/*metabolism

22.0

Lymphocytes/metabolism

20.0

Magnesium/*blood

213.0

Trisaccharides/*therapeutic use

4100.0

Retinol-Binding Proteins/*urine

450.0

Coronary Disease/etiology

38.0

Diabetes Mellitus/*therapy

360.0

Diabetic Retinopathy/*diagnosis

375.0

Injections, Intravenous

40.0

Hexosamines/*blood

2890.0

Pregnancy in Diabetics/*blood/drug therapy

240.0

Diabetes Mellitus, Type 1/*drug therapy/urine

3100.0

Growth Hormone/blood/*secretion

44.0

Diabetes Mellitus, Type 1/blood/psychology/*rehabilitation

3100.0

Hyperinsulinism/blood

218.0

Lipoproteins/*metabolism

21.0

Patient Education/standards

2100.0

Hospitals, Pediatric

240.0

Outpatient Clinics, Hospital

323.0

Oxygen Consumption

41.0

*Physical Fitness

25.0

*Accidents, Traffic

375.0

Diabetes Mellitus, Type 1/metabolism/*physiopathology

583.0

Somatotropin-Releasing Hormone/*pharmacology

44.0

Antihypertensive Agents/therapeutic use

44.0

Diabetes Mellitus, Type 2/*pathology

225.0

*Antiporters

28.0

Insulin/analogs & derivatives/blood

2100.0

Monocytes/*metabolism

20.0

Receptor, Insulin/*metabolism

23.0

South Africa

21.0

Atrial Natriuretic Factor/*blood

23.0

Blood Pressure/*drug effects

31.0

Diabetic Angiopathies/*physiopathology

325.0

Hypertension/*physiopathology

23.0

*Indians, North American

26.0

Chromatography, Liquid/methods

313.0

Glucose/*analysis

233.0

Diabetes Mellitus, Type 1/therapy

240.0

Diabetes Mellitus, Type 2/therapy

266.0

Diabetes Mellitus, Type 1/blood/*drug therapy/physiopathology

2100.0

Insulin, Isophane/*administration & dosage/therapeutic use

2100.0

Diabetes Mellitus, Type 1/*metabolism/therapy

2100.0

Albuminuria/physiopathology

342.0

Insulin/secretion

35.0

Insulin Antibodies/*blood

250.0

Diabetes Mellitus, Type 1/drug therapy/immunology

2100.0

In Vitro

100.0

Diabetes Mellitus, Type 1/blood/*diet therapy

3100.0

Dietary Fiber/*administration & dosage

212.0

Galactans/*administration & dosage

266.0

Mannans/*administration & dosage

266.0

*Weight Loss

36.0

Asia/ethnology

39.0

Research

23.0

Diabetes Mellitus/*metabolism

38.0

Diabetes Mellitus, Type 1/blood/genetics/*physiopathology

266.0

Obesity

1016.0

Nigeria

34.0

Proteinuria/metabolism

214.0

Diabetic Neuropathies/*immunology

2100.0

Image Processing, Computer-Assisted

20.0

Autoanalysis

27.0

Costs and Cost Analysis

46.0

Fetal Hemoglobin/analysis

38.0

Educational Status

23.0

Hypoglycemia/epidemiology/etiology

2100.0

*Heart Rate

48.0

Median Nerve/*physiopathology

220.0

Neurons, Afferent/physiology

310.0

Peroneal Nerve/*physiopathology

360.0

Ulnar Nerve/*physiopathology

2100.0

Antilipemic Agents/*therapeutic use

22.0

C-Peptide/blood/*secretion

350.0

HLA Antigens/analysis

41.0

Hong Kong

36.0

*Family

513.0

Kidney Failure, Chronic/*blood

710.0

Lipoprotein(a)

313.0

Chlorpropamide/therapeutic use

3100.0

Gliclazide/therapeutic use

250.0

Diabetes Mellitus/blood/*psychology

2100.0

Problem Solving

222.0

Delivery, Obstetric

25.0

Community Health Services

228.0

Diabetes Mellitus/*physiopathology

525.0

England

65.0

Diabetes Mellitus/blood/physiopathology

342.0

Glyburide/*administration & dosage

3100.0

Spain

20.0

Diabetes Mellitus, Type 2/*blood/drug therapy

527.0

Diabetes Mellitus, Type 2/*blood/diet therapy/drug therapy

2100.0

Insulin/blood/therapeutic use

350.0

False Positive Reactions

20.0

Peptide Fragments/*pharmacology

31.0

Diabetes Mellitus, Type 1/blood/nursing/*therapy

2100.0

Nursing Assessment/*standards

266.0

Nursing Evaluation Research

228.0

*Self Assessment (Psychology)

240.0

Sex Hormone-Binding Globulin/*metabolism

20.0

Adipose Tissue/*anatomy & histology

35.0

*Body Composition

21.0

Cattle

40.0

Recombinant Proteins/adverse effects/therapeutic use

26.0

Diabetic Ketoacidosis/etiology

360.0

Hypoglycemia/etiology

330.0

Recurrence

20.0

Lipase/metabolism

23.0

Injections, Subcutaneous/methods

375.0

Carrier Proteins/*metabolism

20.0

Glyburide/administration & dosage/*therapeutic use

4100.0

Metformin/administration & dosage/*therapeutic use

250.0

Diabetic Angiopathies/urine

2100.0

Diabetic Retinopathy/urine

3100.0

Hypertension/complications/urine

2100.0

Diabetes Mellitus, Type 1/*urine

555.0

Growth Hormone/*urine

2100.0

Puberty/*urine

266.0

Diabetes Mellitus, Type 2/blood/complications/*drug therapy

233.0

Insulin/blood/*therapeutic use

350.0

Blood Glucose/*physiology

228.0

Electrophoresis, Agar Gel

61.0

Glycosylation/drug effects

26.0

Neutrophils/*physiology

21.0

Staphylococcus aureus

23.0

Diabetes Mellitus, Type 1/blood/*rehabilitation

4100.0

Diabetes Mellitus, Type 2/blood/*rehabilitation

2100.0

Patient Education/*methods

550.0

Blood Glucose/drug effects

210.0

Injections, Subcutaneous

175.0

Diabetic Retinopathy/blood/*physiopathology

375.0

Diabetic Retinopathy/blood/*etiology

2100.0

Doxazosin

266.0

Protirelin/*diagnostic use

22.0

Insulin, Long-Acting/therapeutic use

2100.0

Diabetes Mellitus/drug therapy/*physiopathology

480.0

Thromboxane B2/blood

25.0

Diabetes Mellitus, Type 1/drug therapy/*physiopathology

888.0

Insulin/*adverse effects/therapeutic use

2100.0

Insulin Antibodies/analysis

562.0

Electromyography

21.0

Motor Neurons/*physiology

23.0

Neurons, Afferent/*physiology

27.0

Clinical Protocols

23.0

C-Peptide/*blood/secretion

2100.0

Islets of Langerhans/*secretion

218.0

Arteriosclerosis/*etiology

25.0

Chromatography, Affinity/methods

57.0

Chromatography, Ion Exchange/methods

630.0

Diabetes Mellitus, Type 2/*blood/diet therapy

250.0

Fatty Acids/blood

24.0

Thromboxane B2/*blood

218.0

Hyperlipidemia/blood/complications/*drug therapy

225.0

Attitude to Health

49.0

Diabetes Mellitus, Type 1/blood/*surgery

375.0

Arginine/diagnostic use

311.0

Pancreas Transplantation/methods/*physiology

2100.0

Prolactin/blood

20.0

Diabetic Retinopathy/*metabolism

28.0

Lysine/*analogs & derivatives/analysis

3100.0

*Diet, Reducing

22.0

Electrocardiography

20.0

Monitoring, Physiologic

56.0

Diabetes Mellitus, Type 1/*psychology/therapy

2100.0

Patient Compliance/*psychology

250.0

Hyperglycemia/*complications

342.0

Propanolamines/*therapeutic use

212.0

Serum Albumin/metabolism

31.0

Fetal Macrosomia/*etiology

2100.0

Postpartum Period

45.0

Pregnancy in Diabetics/diagnosis

2100.0

Hemoglobin A, Glycosylated/*physiology

2100.0

*Neural Conduction

630.0

Metformin/adverse effects/*therapeutic use

2100.0

Diabetes Mellitus, Type 1/blood/complications/*urine

2100.0

Hypertension/physiopathology

29.0

Echocardiography

20.0

Transplantation, Homologous

20.0

Diabetes Mellitus, Type 1/blood/metabolism/*psychology

2100.0

*Body Weight

23.0

Diabetes Mellitus, Type 2/blood/complications/*physiopathology

3100.0

Blood Proteins/*metabolism

52.0

Diabetic Nephropathies/blood/therapy

233.0

*Renal Dialysis

20.0

Uremia/*blood/therapy

317.0

Diabetic Retinopathy/*blood/pathology

2100.0

Thyrotropin/blood

71.0

Drug Evaluation

41.0

Parathyroid Hormone/blood

21.0

Diabetes Mellitus/*drug therapy/metabolism

360.0

Glucose/metabolism

83.0

Epinephrine/*blood

27.0

Exertion

45.0

Glipizide/therapeutic use

3100.0

Hypertension/complications/*drug therapy/physiopathology

327.0

Educational Measurement

450.0

*Insulin, Long-Acting

2100.0

Diabetes Mellitus, Type 1/blood/*psychology

9100.0

Diabetes Mellitus/blood/metabolism

266.0

Diabetes Mellitus, Type 1/blood/*drug therapy/immunology

2100.0

Receptors, Interleukin-2

21.0

Diabetic Angiopathies/*drug therapy/metabolism

2100.0

Insulin/*adverse effects

266.0

Respiratory Function Tests

21.0

Apolipoproteins/*blood

42.0

Nifedipine/*therapeutic use

214.0

Delayed-Action Preparations

54.0

Insulin/*administration & dosage/adverse effects

266.0

*Fluorophotometry

2100.0

Immunoglobulin G/analysis

20.0

Vitreous Body/*metabolism

26.0

Glucose Tolerance Test/methods

2100.0

Islets of Langerhans/*immunology

25.0

Oxygen/*blood

24.0

Chromatography, High Pressure Liquid/methods

32.0

History, 20th Century

21.0

*Attitude to Health

618.0

Depression

218.0

Hypoglycemia/*chemically induced

233.0

Continental Population Groups

21.0

Bicarbonates/blood

216.0

Saudi Arabia

24.0

Diabetic Neuropathies/*diagnosis/physiopathology

3100.0

Reaction Time

32.0

*Evoked Potentials, Visual

310.0

Colorimetry

814.0

Peptidyl-Dipeptidase A/*blood

21.0

Thyroxine-Binding Proteins/metabolism

214.0

Triiodothyronine/*blood

310.0

Blood Platelets/metabolism

21.0

Diabetes Mellitus/*blood/prevention & control

2100.0

Apolipoproteins A/blood

45.0

Catheters, Indwelling

216.0

Consumer Satisfaction

342.0

Diabetes Mellitus/blood/drug therapy

228.0

Insulin/administration & dosage/blood/*therapeutic use

375.0

Leukocyte Count

30.0

Aging

30.0

Hemoglobins/metabolism

21.0

Photography

215.0

Outcome and Process Assessment (Health Care)

29.0

Outpatient Clinics, Hospital/*organization & administration

2100.0

Scotland

25.0

Fibrinogen/metabolism

20.0

Partial Thromboplastin Time

21.0

Thrombin Time

29.0

Amino Acids/analysis

20.0

Carbohydrates/*metabolism

25.0

Globins/genetics

21.0

Diabetes Mellitus, Type 2/blood/*psychology

2100.0

Nephelometry and Turbidimetry

22.0

Serum Albumin/*analysis

622.0

Neurologic Examination

43.0

*Diabetes Mellitus, Type 1

250.0

Diabetes Mellitus, Type 1/*psychology

250.0

Antibodies, Monoclonal/diagnostic use

20.0

Diabetes Mellitus, Type 1/*complications/urine

2100.0

Proteinuria/*etiology

215.0

beta 2-Microglobulin/*urine

321.0

Liver Cirrhosis/*blood

25.0

Renin/*blood

22.0

Diabetes Mellitus, Type 1/blood/drug therapy/*psychology

2100.0

*Self Concept

317.0

Injections, Subcutaneous/*instrumentation

2100.0

Insulin/*administration & dosage/blood

4100.0

Hemoglobin A, Glycosylated/blood

6100.0

Diabetes Mellitus, Type 2/blood/*drug therapy/metabolism

2100.0

Immunoglobulin G/urine

222.0

Hair/*analysis

250.0

Edetic Acid/pharmacology

21.0

Heparin/pharmacology

20.0

Peripheral Nerves/*physiopathology

666.0

*Cognition

24.0

Insulin Infusion Systems/*adverse effects

2100.0

Insulin-Like Growth Factor I/*blood

220.0

Somatomedins/*blood

212.0

*Drug Therapy, Computer-Assisted

266.0

Life Style

21.0

Insulin Antibodies/*analysis

466.0

Diabetes Mellitus, Type 1/*surgery

266.0

Hemoglobin A/*analogs & derivatives/metabolism

2100.0

Peritoneal Dialysis, Continuous Ambulatory

24.0

Renal Dialysis

72.0

Fetal Macrosomia/blood

266.0

Germany, East

228.0

*Prenatal Diagnosis

20.0

Hypoglycemia/chemically induced

233.0

Insulin/blood/*pharmacology

210.0

Diabetes Mellitus, Type 2/blood/drug therapy

266.0

*Food

22.0

ROC Curve

21.0

Erythrocyte Volume

210.0

Peripheral Nervous System Diseases/*physiopathology

250.0

Synaptic Transmission

25.0

Diabetes Mellitus, Type 2/blood/drug therapy/*physiopathology

250.0

Regional Blood Flow/drug effects

21.0

Diabetes Mellitus, Type 1/blood/*drug therapy/metabolism

2100.0

Lipids/*metabolism

20.0

HLA Antigens/*analysis

30.0

Diet

20.0

Fibronectins/*blood

311.0

Reagent Strips

266.0

Insulin, Isophane/*therapeutic use

2100.0

Kidney Transplantation

32.0

Hemoglobin A, Glycosylated/*blood

2100.0

Diabetic Retinopathy/immunology

266.0

Diabetic Neuropathies/drug therapy/*physiopathology

3100.0

Blood Proteins/*analysis

42.0

Laboratory Techniques and Procedures

310.0

Myocardial Infarction/blood

25.0

Dietary Carbohydrates/administration & dosage

414.0

Glycosuria/metabolism

266.0

3-Hydroxybutyric Acid

320.0

Hydroxybutyrates/blood

531.0

Apolipoproteins B/*blood

21.0

Protirelin/*pharmacology

22.0

Triiodothyronine/blood

62.0

Drug Combinations

30.0

Glyburide/pharmacology/*therapeutic use

2100.0

Pyruvates/blood

220.0

Diabetes Mellitus, Type 1/blood/*diagnosis

375.0

Diabetes Mellitus, Type 1/*drug therapy/psychology

2100.0

C-Peptide/secretion

350.0

Muscles/*enzymology

22.0

Blood Platelets/*physiology

21.0

*Chromatography, Affinity

218.0

Thyroid Hormones/*blood

58.0

Galactans/*therapeutic use

4100.0

Mannans/*therapeutic use

4100.0

Blood Cell Count

20.0

Reticulocytes

26.0

Diabetes Mellitus, Type 1/blood/diet therapy/*drug therapy

2100.0

Erythrocytes/*analysis

614.0

Sorbitol/*blood

266.0

*Platelet Aggregation

33.0

Erythrocytes/analysis

520.0

Skin Temperature

25.0

Diabetes Mellitus, Type 1/*blood/therapy

375.0

Diabetic Neuropathies/complications

266.0

Lipoproteins, HDL/*blood

73.0

*Blood Glucose

327.0

Dietary Fiber/*therapeutic use

225.0

Antithrombin III/*metabolism

34.0

Liver/metabolism

20.0

Obesity/blood

25.0

Pregnancy in Diabetics/*drug therapy

375.0

Food, Formulated

26.0

Insulin/*secretion/therapeutic use

2100.0

Cyanates/metabolism

2100.0

Rheology

34.0

Viscosity

26.0

*Insulin Infusion Systems/adverse effects

4100.0

Diabetes Mellitus, Type 1/*blood/complications/drug therapy

375.0

*Peritoneal Dialysis, Continuous Ambulatory

21.0

Self Administration

225.0

*Monitoring, Physiologic

218.0

Diabetic Retinopathy/*etiology

250.0

Glycogen/metabolism

24.0

*Exertion

42.0

Monocytes/metabolism

30.0

Apolipoprotein A-I

43.0

Diabetes Mellitus, Type 1/drug therapy

250.0

Parent-Child Relations

220.0

Chromatography/methods

414.0

Peritoneal Dialysis

25.0

Glycosuria/diagnosis

8100.0

Monitoring, Physiologic/*methods

320.0

Eating Disorders/*complications

2100.0

Specimen Handling

33.0

Fetus/physiology

36.0

Methods

41.0

Erythrocytes/metabolism

42.0

Reagent Kits, Diagnostic

53.0

Diabetes Mellitus/*drug therapy

327.0

Home Nursing

2100.0

Thiobarbiturates

457.0

Pregnancy in Diabetics/*diagnosis

2100.0

Diabetes Mellitus, Type 1/*blood/immunology

250.0

Diabetes Mellitus/blood/*metabolism

240.0

*Chromatography

337.0

*Electrophoresis

225.0

*Electrophoresis, Agar Gel

240.0

Blood Preservation

34.0

Antigens/*analysis

22.0

von Willebrand Factor

310.0

Uric Acid/blood

35.0

Beta-Globulins/*analysis

512.0

beta-Thromboglobulin/*analysis

513.0

Hypoglycemia/blood

240.0

*Cardiac Output

220.0

*Stroke Volume

225.0

Technetium/diagnostic use

27.0

Blood Urea Nitrogen

23.0

Hemoglobin A, Glycosylated/*biosynthesis

2100.0

Diabetes Mellitus/blood/*therapy

2100.0

Homeostasis

20.0

Collagen/pharmacology

21.0

Insulin/*immunology

216.0

Diabetes Mellitus, Type 2/drug therapy

233.0

Lipoproteins, HDL Cholesterol

919.0

Erythrocyte Aging

412.0

Thyroxine-Binding Proteins/analysis

321.0

Triiodothyronine, Reverse/blood

310.0

Indicators and Reagents

20.0

Chromatography

74.0

*Chromatography, Ion Exchange

266.0

Glycosuria/*diagnosis

2100.0

Lipoproteins, LDL Cholesterol

416.0

Lipoproteins, VLDL Cholesterol

215.0

Diabetes Mellitus/drug therapy

218.0

*Pregnancy

53.0

*Blood Preservation

23.0

*Forensic Medicine

24.0

Remission, Spontaneous

34.0

Antibodies/*analysis

21.0

Blood Protein Electrophoresis

21.0

Hemoglobin A, Glycosylated/*analysis/biosynthesis

2100.0

Chromatography/*methods

215.0

Microchemistry

26.0

Blood Proteins/metabolism

20.0

Trypsin/blood

240.0

Hemoglobin A/*analogs & derivatives/analysis

8100.0

Hemoglobin A/*analysis

2656.0

Chromatography, Ion Exchange/*methods

444.0

Diabetes Mellitus/*drug therapy/immunology

2100.0

Insulin Antibodies/*immunology

250.0

*Postpartum Period

25.0

Cold

21.0

Organ Size

21.0

Peptides/*blood

22.0

Glycosides/*analysis

990.0

Hemoglobin A/*analogs & derivatives/*analysis

3100.0

Glycosides/analysis

250.0

Blood Glucose/analysis/metabolism

222.0

Glycosides/blood

266.0